AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteAtipamezole HCl is a selective ??2-adrenergic receptor antagonist (Ki values are 1.1, 1.0, 0.89, 1300 and 6500 nM for ??2A, ??2B, ??2C, ??1A and ??1B receptors respectively). Has been shown to be a brain penetrant.
More Information Supplier PageAtipamezole HCl is a selective ??2-adrenergic receptor antagonist (Ki values are 1.1, 1.0, 0.89, 1300 and 6500 nM for ??2A, ??2B, ??2C, ??1A and ??1B receptors respectively). Has been shown to be a brain penetrant.
More Information Supplier PageAtipamezole HCl is a selective ??2-adrenergic receptor antagonist (Ki values are 1.1, 1.0, 0.89, 1300 and 6500 nM for ??2A, ??2B, ??2C, ??1A and ??1B receptors respectively). Has been shown to be a brain penetrant.
More Information Supplier PageAtomoxetine hydrochloride is a competitive and specific inhibitor of SLC6A2 while demonstrating weak ST and DAT inhibition as studied in synaptosomes of rat hypothalamus.
More Information Supplier PageAtomoxetine hydrochloride is a competitive and specific inhibitor of SLC6A2 while demonstrating weak ST and DAT inhibition as studied in synaptosomes of rat hypothalamus.
More Information Supplier PageAtomoxetine hydrochloride is a competitive and specific inhibitor of SLC6A2 while demonstrating weak ST and DAT inhibition as studied in synaptosomes of rat hypothalamus.
More Information Supplier PageAtopaxar hydrobromide shows potent inhibitory effects on human platelet aggregation induced by thrombin and TRAP with IC values of 0.064 and 0.031 ??M respectively.
More Information Supplier PageAtopaxar hydrobromide shows potent inhibitory effects on human platelet aggregation induced by thrombin and TRAP with IC values of 0.064 and 0.031 ??M respectively.
More Information Supplier PageAtopaxar hydrobromide shows potent inhibitory effects on human platelet aggregation induced by thrombin and TRAP with IC values of 0.064 and 0.031 ??M respectively.
More Information Supplier PageAtorvastatin is an HMG-CoA reductase inhibitor (IC50 = 154 nM) that is effective in treating hypercholesterolemia and certain dyslipidemias.
More Information Supplier PageAtorvastatin is an HMG-CoA reductase inhibitor (IC50 = 154 nM) that is effective in treating hypercholesterolemia and certain dyslipidemias.
More Information Supplier PageAtorvastatin (Lipitor) is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of cholesterol.
More Information Supplier PageAtorvastatin (Lipitor) is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of cholesterol.
More Information Supplier PageAtorvastatin (Lipitor) is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of cholesterol.
More Information Supplier PageAtorvastatin (Lipitor) is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of cholesterol.
More Information Supplier PageAtorvastatin (Lipitor) is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of cholesterol.
More Information Supplier PageAtovaquone is an anti-protozoal mitochondrial electron transport inhibitor.
More Information Supplier PageATP (Adenosine-Triphosphate) is a nucleoside triphosphate used in cells as a coenzyme. It is often called the “molecular unit of currency” of intracellular energy transfer. ATP transports chemical energy within cells for metabolism. It is one of the end products of photophosphorylation, cellular respiration, and fermentation and used by enzymes and structural proteins in many […]
More Information Supplier PageAtractylenolide I (AO-I) is one of the major bioactive components from Rhizoma Atractylodes macrocephala.
More Information Supplier PageAtractylenolide I (AO-I) is one of the major bioactive components from Rhizoma Atractylodes macrocephala.
More Information Supplier PageAtractylenolide I (AO-I) is one of the major bioactive components from Rhizoma Atractylodes macrocephala.
More Information Supplier PageAtractylenolide III is the major bioactive component of Atractylodes lancea.
More Information Supplier PageAtractylenolide III is the major bioactive component of Atractylodes lancea.
More Information Supplier PageAtractylenolide III is the major bioactive component of Atractylodes lancea.
More Information Supplier PageAtractyloside is a natural heteroglucoside produced in some plants, including A. gummifera.
More Information Supplier PageAtractyloside is a natural heteroglucoside produced in some plants, including A. gummifera.
More Information Supplier PageAtractyloside is a natural heteroglucoside produced in some plants, including A. gummifera.
More Information Supplier PageAtracurium besylate is a neuromuscular blocking agent with ED95 of 0.2 mg/kg.
More Information Supplier PageAtracurium besylate is a neuromuscular blocking agent with ED95 of 0.2 mg/kg.
More Information Supplier PageAtracurium besylate is a neuromuscular blocking agent with ED95 of 0.2 mg/kg.
More Information Supplier PageAtracurium besylate is a neuromuscular blocking agent with ED95 of 0.2 mg/kg.
More Information Supplier PageAtrasentan is an experimental drug that is being studied for the treatment of various types of cancer, including non-small cell lung cancer. It is an endothelin receptor antagonist selective for subtype A (ETA).
More Information Supplier PageAtrasentan is an experimental drug that is being studied for the treatment of various types of cancer, including non-small cell lung cancer. It is an endothelin receptor antagonist selective for subtype A (ETA).
More Information Supplier PageAtrasentan is an experimental drug that is being studied for the treatment of various types of cancer, including non-small cell lung cancer. It is an endothelin receptor antagonist selective for subtype A (ETA).
More Information Supplier PageAtrasentan hydrochloride is an endothelin antagonist receptor (IC50=0.0551 nM, ETA) being developed for the treatment of prostate cancer.
More Information Supplier PageAtrasentan hydrochloride is an endothelin antagonist receptor (IC50=0.0551 nM, ETA) being developed for the treatment of prostate cancer.
More Information Supplier PageAtrasentan hydrochloride is an endothelin antagonist receptor (IC50=0.0551 nM, ETA) being developed for the treatment of prostate cancer.
More Information Supplier PageAtropine is a competitive antagonist for the muscarinic acetylcholine receptor types M1, M2, M3, M4 and M5.
More Information Supplier PageAtropine is a competitive antagonist for the muscarinic acetylcholine receptor types M1, M2, M3, M4 and M5.
More Information Supplier PageAtropine is a competitive antagonist for the muscarinic acetylcholine receptor types M1, M2, M3, M4 and M5.
More Information Supplier PageAtropine is a competitive antagonist for the muscarinic acetylcholine receptor types M1, M2, M3, M4 and M5.
More Information Supplier Page
